Cadrenal Therapeutics (CVKD) Institutional Ownership $14.20 -0.30 (-2.07%) (As of 01:15 PM ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Cadrenal Therapeutics (NASDAQ:CVKD)CurrentInstitutional OwnershipPercentage7.92%Number ofInstitutional Buyers(last 12 months)0Number ofInstitutional Sellers(last 12 months)2 Get CVKD Insider Trade Alerts Want to know when executives and insiders are buying or selling Cadrenal Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Ad Crypto Swap Profits[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin Cadrenal Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/9/2024 Renaissance Technologies LLC59,491$28K0.0%-59.8%0.372% 2/13/2024 Armistice Capital LLC414,285$307K0.0%-57.8%3.182% 11/15/2023 Armistice Capital LLC982,285$668K0.0%N/A7.544% (Data available from 1/1/2016 forward) CVKD Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CVKD shares? During the previous two years, the following institutional investors and hedge funds held shares of Cadrenal Therapeutics shares: Armistice Capital LLC ($307K), Renaissance Technologies LLC ($28K).Learn more on CVKD's institutional investors. What percentage of Cadrenal Therapeutics stock is owned by institutional investors? 7.92% of Cadrenal Therapeutics stock is owned by institutional investors. Learn more on CVKD's institutional investor holdings. Which institutional investors have been buying Cadrenal Therapeutics stock? The following institutional investors have purchased Cadrenal Therapeutics stock in the last 24 months: Armistice Capital LLC ($982.29K). How much institutional buying is happening at Cadrenal Therapeutics? Institutional investors have bought a total of 982,285 shares in the last 24 months. This purchase volume represents approximately $0.00 in transactions. Which Cadrenal Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Cadrenal Therapeutics stock in the last 24 months: Armistice Capital LLC ($568K), and Renaissance Technologies LLC ($88.65K). How much institutional selling is happening at Cadrenal Therapeutics? Institutional investors have sold a total of 656,647 shares in the last 24 months. This volume of shares sold represents approximately $0.00 in transactions. Related Companies NVCT Institutional Ownership ANVS Institutional Ownership ASRT Institutional Ownership QNCX Institutional Ownership PWUP Institutional Ownership IVVD Institutional Ownership GBIO Institutional Ownership GNTA Institutional Ownership GNLX Institutional Ownership SLS Institutional Ownership This page (NASDAQ:CVKD) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cadrenal Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cadrenal Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CVKD Stock Alerts